glp-1 next generation history of glp 1 agonists A timeline GLP- discovery and clinical development. Created in receptor agonists and next-generation – GLP-1S | Next Gen Peptides

In controlled laboratory and pre-clinical settings, Melanotan 1 is studied across MC1R receptor pharmacology, melanogenesis biology, photoprotection, skin immunology, anti-inflammatory biology, and comparative melanocortin agonist research applications: MT-1 is the primary reference agonist for MC1R pharmacology , used to characterise receptor binding kinetics and affinity, Gs-coupled cAMP-PKA signal transduction downstream of MC1R engagement, MITF transcription factor activation and downstream melanogenesis gene upregulation, tyrosinase and TYRP1/TYRP2 enzyme expression and activity, and melanosome biogenesis and transfer to keratinocytes

P.MoisS

Belli M, Barone L, Bellia A, et al

These two antioxidants combined have been found to slow down the aging process, protect the skin from UV rays and pollutants, while also managing inflammation and lipid peroxidation